Heman Lapman Chao
Direttore/Membro del Consiglio presso Helix Immuno-Oncology SA
Posizioni attive di Heman Lapman Chao
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Helix Immuno-Oncology SA
 Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Heman Lapman Chao
Precedenti posizioni note di Heman Lapman Chao
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HELIX BIOPHARMA CORP. | Direttore/Membro del Consiglio | 12/12/2017 | 01/09/2021 |
| Amministratore Delegato | 31/03/2017 | 01/09/2021 | |
| Direttore Tecnico/Scientifico/R&S | 01/06/2002 | 01/09/2021 | |
Sensium Technologies, Inc.
 Sensium Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Helix BioPharma Corp., Sensium Technologies, Inc. researches and develops drugs and vaccines. Sensium Technologies was acquired by Helix BioPharma Corp. on December 10, 2002 for $3.83 million. | Presidente | 01/11/2004 | 01/04/2008 |
Sensium Technologies, Inc.
Sensium Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Helix BioPharma Corp., Sensium Technologies, Inc. researches and develops drugs and vaccines. Sensium Technologies was acquired by Helix BioPharma Corp. on December 10, 2002 for $3.83 million. | Corporate Officer/Principal | 01/01/1999 | 01/06/2002 |
Formazione di Heman Lapman Chao
| Queen's University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Canada | 4 |
| Polonia | 2 |
Posizioni
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HELIX BIOPHARMA CORP. | Health Technology |
| Aziende private | 2 |
|---|---|
Sensium Technologies, Inc.
Sensium Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Helix BioPharma Corp., Sensium Technologies, Inc. researches and develops drugs and vaccines. Sensium Technologies was acquired by Helix BioPharma Corp. on December 10, 2002 for $3.83 million. | Commercial Services |
Helix Immuno-Oncology SA
Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Health Technology |
- Borsa valori
- Insiders
- Heman Lapman Chao
- Esperienza
